Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xian Lin

Showing results (721-730 of 850) with videos related to

Pageof 85
Sort By:
BMC Gastroenterology|December 4, 2019
Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer-an east and west multicenter studyZe-Ning Huang, Jacopo Desiderio, Qi-Yue Chen, et al.
Annals of Surgical Oncology|November 22, 2022
Patient-Reported Outcomes of Individuals with Gastric Cancer Undergoing Totally Laparoscopic Versus Laparoscopic-Assisted Total Gastrectomy: A Real-World, Propensity Score-Matching AnalysisGuang-Tan Lin, Jun-Yu Chen, Qi-Yue Chen, et al.
Cancer Research|December 1, 2023
Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric CancerRu-Hong Tu, Sheng-Ze Wu, Ze-Ning Huang, et al.
British Journal of Cancer|May 27, 2020
Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancerJun-Peng Lin, Jian-Xian Lin, Yu-Bin Ma, et al.
Annals of Surgical Oncology|February 14, 2019
Does Noncompliance in Lymph Node Dissection Affect Oncological Efficacy in Gastric Cancer Patients Undergoing Radical Gastrectomy?Qi-Yue Chen, Qing Zhong, Zhi-Yu Liu, et al.
Cancer Letters|October 30, 2016
CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signalingJia-Bin Wang, Zu-Wei Wang, Yun Li, et al.
Epidemiology (Cambridge, Mass.)|May 28, 2025
Potential Impact of Maternal Nighttime Light Exposure and Its Interaction With Sociodemographic Characteristics on the Risk of Various Congenital Heart DiseasesShanidewuhaxi Tuohetasen, Yanji Qu, Philip K Hopke, et al.
International Journal of Surgery (London, England)|July 9, 2024
Development and validation of a preoperative radiomics-based nomogram to identify patients who can benefit from splenic hilar lymphadenectomy: a pooled analysis of three prospective trialsBin-Bin Xu, Hua-Long Zheng, Chun-Sen Chen, et al.
Nature Communications|January 3, 2024
Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trialJian-Xian Lin, Yi-Hui Tang, Hua-Long Zheng, et al.
Medicine|January 18, 2019
What is the appropriate duration of adjuvant imatinib mesylate treatment for primary gastrointestinal stromal tumors classified according to the strict definition of tumor rupture?Jun Lu, Yun Dai, Hua-Long Zheng, et al.
Pageof 85

Showing results (721-730 of 850) with videos related to

Sort By:
Pageof 85
BMC Gastroenterology|December 4, 2019
Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer-an east and west multicenter studyZe-Ning Huang, Jacopo Desiderio, Qi-Yue Chen, et al.
Annals of Surgical Oncology|November 22, 2022
Patient-Reported Outcomes of Individuals with Gastric Cancer Undergoing Totally Laparoscopic Versus Laparoscopic-Assisted Total Gastrectomy: A Real-World, Propensity Score-Matching AnalysisGuang-Tan Lin, Jun-Yu Chen, Qi-Yue Chen, et al.
Cancer Research|December 1, 2023
Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric CancerRu-Hong Tu, Sheng-Ze Wu, Ze-Ning Huang, et al.
British Journal of Cancer|May 27, 2020
Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancerJun-Peng Lin, Jian-Xian Lin, Yu-Bin Ma, et al.
Annals of Surgical Oncology|February 14, 2019
Does Noncompliance in Lymph Node Dissection Affect Oncological Efficacy in Gastric Cancer Patients Undergoing Radical Gastrectomy?Qi-Yue Chen, Qing Zhong, Zhi-Yu Liu, et al.
Cancer Letters|October 30, 2016
CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signalingJia-Bin Wang, Zu-Wei Wang, Yun Li, et al.
Epidemiology (Cambridge, Mass.)|May 28, 2025
Potential Impact of Maternal Nighttime Light Exposure and Its Interaction With Sociodemographic Characteristics on the Risk of Various Congenital Heart DiseasesShanidewuhaxi Tuohetasen, Yanji Qu, Philip K Hopke, et al.
International Journal of Surgery (London, England)|July 9, 2024
Development and validation of a preoperative radiomics-based nomogram to identify patients who can benefit from splenic hilar lymphadenectomy: a pooled analysis of three prospective trialsBin-Bin Xu, Hua-Long Zheng, Chun-Sen Chen, et al.
Nature Communications|January 3, 2024
Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trialJian-Xian Lin, Yi-Hui Tang, Hua-Long Zheng, et al.
Medicine|January 18, 2019
What is the appropriate duration of adjuvant imatinib mesylate treatment for primary gastrointestinal stromal tumors classified according to the strict definition of tumor rupture?Jun Lu, Yun Dai, Hua-Long Zheng, et al.
Pageof 85